Pathways | P value | Genes impacted |
---|---|---|
FXR/RXR Activation | 3.66E-07 | ABCC2, IL18, APOB, SCARB1, FABP6, APOC3, APOA1, APOC2 |
LXR/RXR Activation | 2.78E-04 | IL18, APOA4, APOA1, CD36, APOC2 |
LPS/IL-1 Mediated Inhibition of RXR Function | 8.80E-04 | ABCC2, SCARB1, FABP6, CYP3A4, APOC2, FMO5, SULT1B1 |
Arachidonic Acid Metabolism | 4.68E-03 | CYP4F2, AKR1C3, CYP3A4, CYP4B1, GGT1 |
Nicotinate and Nicotinamide Metabolism | 7.08E-03 | ENPP3, VNN1, NT5E, BST1 |
T Helper Cell Differentiation | 1.56E-02 | IL18, IL21R, CXCR5 |
Xenobiotic Metabolism Signaling | 2.19E-02 | ABCC2, CYP3A4, PPP2R2C, FMO5, MAPK11, SULT1B1 |
Inhibition of Angiogenesis by TSP1 | 2.45E-02 | CD36, MAPK11 |
Interferon Signaling | 2.74E-02 | OAS1, MX1 |
Cell Cycle Regulation by BTG Family Proteins | 2.89E-02 | CCNE2, PPP2R2C |
Pyrimidine Metabolism | 3.05E-02 | ENPP3, NT5E, ENTPD5, CTPS2 |
Acute Phase Response Signaling | 4.21E-02 | IL18, APOA1, RBP2, MAPK11 |